Home
About
Overview
Sharing Data
ORCID
Help
History (117)
Bioethics
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.
Efficacy of parenteral methotrexate in refractory Crohn's disease.
A comparison of DSM-IV pervasive developmental disorder and DSM-5 autism spectrum disorder prevalence in an epidemiologic sample.
Loss of cyclin D1 impairs cerebellar development and suppresses medulloblastoma formation.
See All 117 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Loss of cyclin D1 impairs cerebellar development and suppresses medulloblastoma formation.
Loss of cyclin D1 impairs cerebellar development and suppresses medulloblastoma formation. Development. 2006 Oct; 133(19):3929-37.
View in:
PubMed
subject areas
Animals
Cell Proliferation
Cerebellar Neoplasms
Cerebellum
Cyclin D
Cyclin D2
Cyclins
Medulloblastoma
Mice
Mice, Mutant Strains
Neurons
Patched Receptors
Patched-1 Receptor
Precancerous Conditions
Purkinje Cells
Receptors, Cell Surface
Up-Regulation
authors with profiles
Wei Du
Manuel F. Utset